- Exon skipping and alternative splice-site selection are important forms of alternative splicing in eukaryotic organisms. They allow a single gene to produce multiple messenger RNA (mRNA) transcripts by changing which parts of a precursor messenger RNA (pre-mRNA) are retained during RNA processing. These mechanisms contribute to transcript diversity, protein variation, tissue-specific gene expression, development, and cellular regulation. They are also important in disease biology because mutations or regulatory changes affecting exon selection and splice-site recognition can produce abnormal transcripts and dysfunctional proteins. Bioinformatics approaches, particularly RNA sequencing (RNA-seq) and transcript isoform analysis, are widely used to identify and investigate these splicing events.
- Eukaryotic genes generally contain exons and introns. Exons are sequences retained in mature RNA, while introns are intervening sequences that are usually removed during RNA processing. Following transcription, the pre-mRNA is processed by the spliceosome, a dynamic molecular complex composed of small nuclear ribonucleoproteins (snRNPs) and associated proteins. The spliceosome recognizes specific RNA sequences at exon–intron boundaries, removes introns, and joins the selected exons. The major spliceosomal components include U1, U2, U4, U5, and U6 snRNPs. Their coordinated activity ensures accurate RNA processing and contributes to the selection of alternative splice sites.
- Exon skipping, also known as cassette exon splicing, occurs when a particular exon is included in some mature transcripts but excluded from others. In a simplified gene containing four exons, a transcript may contain all four exons, while another transcript may contain only exons 1, 2, and 4 because exon 3 has been skipped. The two transcripts originate from the same pre-mRNA but differ in their exon composition. Exon skipping is one of the most common forms of alternative splicing in many eukaryotic organisms and can substantially influence the structure and function of the resulting protein.
- When an exon is included, the spliceosome recognizes the splice sites surrounding that exon and joins it to the adjacent exons. When the exon is skipped, the spliceosome connects the upstream exon directly to the downstream exon. This alternative selection changes the exon–exon junction in the mature transcript. Exon skipping may remove a complete protein domain, a portion of a functional region, or a sequence involved in protein interactions. Depending on the location and length of the skipped exon, it may also alter the reading frame and introduce a premature termination codon.
- Alternative splice-site selection occurs when the spliceosome uses different 5′ or 3′ splice sites within a gene. The 5′ splice site marks the beginning of an intron, while the 3′ splice site marks its end. Alternative selection of these sites changes the boundaries of the retained exons. Unlike complete exon skipping, alternative splice-site selection often changes only part of an exon, producing transcripts that differ by a shorter sequence region. These changes may affect protein structure, regulatory sequences, and RNA stability.
- Alternative 5′ splice-site selection, also called alternative donor-site selection, occurs when different 5′ splice sites are used within the same region. This changes the upstream boundary of the downstream exon. Depending on which donor site is selected, the mature transcript may contain a longer or shorter exon. Alternative 3′ splice-site selection, also known as alternative acceptor-site selection, occurs when different 3′ splice sites are used, changing the downstream boundary of the upstream exon. Both mechanisms can alter the coding sequence or untranslated regions of the resulting transcript.
- Splice-site recognition depends on specific RNA sequence signals. The 5′ splice site commonly contains a GU dinucleotide at the beginning of the intron, while the 3′ splice site commonly ends with an AG dinucleotide. Additional recognition elements include the branch point sequence, which contains an important adenine nucleotide, and the polypyrimidine tract, which is rich in cytosine and uracil. The spliceosome uses these sequences together with surrounding regulatory elements to identify appropriate splice sites. Differences in splice-site strength can influence whether a particular site is selected or whether an alternative site is used.
- The regulation of exon skipping and alternative splice-site selection involves cis-acting RNA elements and trans-acting splicing factors. Cis-acting elements are regulatory sequences located within the pre-mRNA. They include exonic splicing enhancers (ESEs), exonic splicing silencers (ESSs), intronic splicing enhancers (ISEs), and intronic splicing silencers (ISSs). Enhancers generally promote recognition of particular splice sites, whereas silencers can reduce their use. Their effects depend on the sequence, location, RNA structure, and proteins that bind to them.
- Serine/arginine-rich (SR) proteins are important splicing regulators that frequently promote splice-site recognition by binding to enhancer elements. Heterogeneous nuclear ribonucleoproteins (hnRNPs) can influence splicing by binding to regulatory sequences and promoting or suppressing specific exon-selection patterns. Other regulatory proteins, including NOVA, RBFOX, PTBP, and MBNL, contribute to tissue-specific and developmental splicing. Differences in the abundance and activity of these factors help explain why the same gene may produce different transcript isoforms in muscle, brain, liver, reproductive tissues, and other cell types.
- Exon skipping and alternative splice-site selection can have different consequences for protein structure. If a skipped exon contains a complete protein domain, its removal may produce an isoform with a different biological function. If the exon contains only a small coding region, the resulting protein may lose a binding site, active-site residue, or regulatory sequence. Alternative donor or acceptor selection may add or remove a smaller number of amino acids, potentially changing protein stability, folding, interactions, or cellular localization. These effects depend on the position and functional importance of the affected sequence.
- The reading frame is particularly important when interpreting exon-skipping events. If the number of coding nucleotides removed is divisible by three, the downstream reading frame may remain unchanged, although amino acids are still removed from the protein. If the number is not divisible by three, the reading frame may shift, potentially producing an altered amino acid sequence and a premature termination codon. Such transcripts may be targeted by nonsense-mediated mRNA decay (NMD), a cellular mechanism that degrades certain mRNAs containing premature termination codons. Consequently, exon skipping may influence both protein diversity and the abundance of particular transcripts.
- Alternative splice-site selection can also affect untranslated regions (UTRs). The 5′ UTR and 3′ UTR contain regulatory sequences that influence translation, RNA stability, localization, and interactions with RNA-binding proteins and microRNAs. Alternative 5′ or 3′ splice-site selection within these regions may change the regulatory properties of an mRNA without altering its protein-coding sequence. This demonstrates that alternative splicing can influence gene expression even when the resulting protein sequence remains unchanged.
- Exon skipping and alternative splice-site selection are involved in normal development and tissue-specific gene regulation. During embryonic development, different transcript isoforms may be required for cell differentiation and organ formation. In muscle, alternative splicing contributes to the production of protein variants involved in contraction and structural organization. In the nervous system, splicing differences support neuronal development, synaptic function, and communication between cells. Immune cells also use alternative splicing to regulate receptor structures, signalling proteins, and immune responses.
- Abnormal exon skipping and splice-site selection are associated with several genetic and acquired diseases. Mutations in canonical splice sites can prevent normal recognition of exon–intron boundaries. Variants in enhancer or silencer sequences may change the inclusion of specific exons, while mutations in splicing-factor genes can affect multiple transcripts. In cancer, abnormal splicing can produce isoforms involved in uncontrolled cell growth, apoptosis, metabolism, tumour progression, and drug resistance. In inherited disorders, mutations that cause exon skipping or abnormal splice-site selection may lead to missing protein regions, frameshifts, or premature termination codons.
- Bioinformatics provides powerful methods for identifying exon skipping and alternative splice-site events from RNA-seq data. In a typical workflow, raw sequencing reads undergo quality control using FastQC and MultiQC, followed by adapter removal and filtering with tools such as Cutadapt or fastp. Cleaned reads are aligned to a reference genome using splice-aware aligners such as STAR or HISAT2. These aligners identify reads spanning exon–exon junctions, providing evidence about which exons and splice sites are used in each sample.
- For exon-skipping analysis, researchers examine reads supporting inclusion of the alternative exon and reads supporting the direct connection between the flanking exons. Inclusion-supporting evidence may include reads spanning the junction between the upstream exon and the alternative exon, as well as reads spanning the junction between the alternative exon and the downstream exon. Exclusion-supporting reads span the junction connecting the upstream and downstream exons directly. The relative abundance of these reads provides information about the inclusion level of the exon.
- Percent spliced in (PSI) is commonly used to estimate the proportion of transcripts containing a particular exon or splicing feature. For a simple exon-skipping event, it can be represented as:
- PSI = Inclusion-supporting reads / (Inclusion-supporting reads + Exclusion-supporting reads)
- Here, inclusion-supporting reads provide evidence that the alternative exon is included, while exclusion-supporting reads provide evidence that the exon is skipped. PSI ranges from 0 to 1, or from 0% to 100% when expressed as a percentage. A higher PSI indicates greater exon inclusion, while a lower PSI indicates greater exon skipping. In practical analyses, software may use event-specific normalization, junction lengths, and statistical models rather than relying on a simple unadjusted read ratio.
- The difference in exon inclusion between two biological conditions can be expressed as:
- ΔPSI = PSI(condition 1) − PSI(condition 2)
- A positive ΔPSI indicates increased exon inclusion in condition 1 relative to condition 2, while a negative value indicates reduced inclusion. Researchers use ΔPSI together with statistical significance and adjusted p-values to identify differential splicing events. Biological replicates are important because splicing patterns can vary naturally among individuals and experimental samples.
- Several specialized bioinformatics tools support the analysis of exon skipping and alternative splice-site selection. rMATS identifies differential alternative splicing events between experimental conditions and classifies events into major categories, including skipped exons, alternative 5′ splice sites, alternative 3′ splice sites, mutually exclusive exons, and retained introns. SUPPA2 estimates splicing events using transcript abundance measurements. MAJIQ identifies local splicing variations, while LeafCutter detects differential intron usage based on reads spanning splice junctions. These tools use different statistical models and event definitions, so researchers should consider their analytical assumptions when comparing results.
- Transcript assembly and isoform quantification provide complementary information. StringTie can reconstruct transcript structures from RNA-seq alignments, while Salmon and kallisto estimate transcript abundance using efficient mapping-based or pseudoalignment approaches. Transcript-level analysis helps determine whether an exon-skipping event produces a distinct transcript isoform and whether its relative abundance changes between samples. Long-read sequencing technologies, including Oxford Nanopore and Pacific Biosciences, can provide additional evidence by sequencing longer RNA-derived molecules that span multiple exons and splice junctions.
- Functional interpretation is an important stage of exon-skipping and alternative splice-site analysis. Researchers can examine whether the affected exons encode protein domains, catalytic sites, binding regions, signal peptides, or transmembrane segments. Resources such as Ensembl, GENCODE, RefSeq, UniProt, Pfam, and InterPro provide transcript and protein annotations. Tools such as InterProScan can identify conserved protein domains, while IsoformSwitchAnalyzeR supports the investigation of transcript switching and potential functional consequences. Predicted protein changes should be interpreted cautiously because transcript detection does not automatically establish that a stable protein is produced.
- Experimental validation helps confirm computationally identified splicing events. Reverse transcription PCR (RT-PCR) can amplify regions surrounding an alternative exon, producing different-sized fragments depending on whether the exon is included or skipped. Gel electrophoresis can distinguish these products, and Sanger sequencing can confirm the corresponding exon–exon junctions. RT-qPCR using isoform-specific primers can quantify selected transcripts. Long-read sequencing can further verify complete transcript structures, while Western blotting or mass spectrometry may help establish whether alternative transcripts produce distinct protein products.
- In animal genomics and quantitative genetics, exon skipping and alternative splice-site selection can contribute to variation in important production and fitness traits. Differences in transcript isoforms may affect muscle development, growth, milk synthesis, fertility, immune function, feed efficiency, and environmental adaptation. For example, exon skipping in muscle-related genes may change protein domains involved in muscle structure or contraction. Alternative splice-site selection in metabolic genes may influence protein activity and nutrient utilization. Investigating these events across breeds, tissues, developmental stages, and environmental conditions can help explain molecular differences associated with complex animal traits.
- Reliable analysis requires appropriate experimental design and careful interpretation. Researchers should consider sequencing depth, read quality, genome assembly, transcript annotation, sample size, biological replication, and tissue composition. Low-abundance transcripts and weakly supported splice junctions can produce uncertain results. Batch effects and differences in experimental conditions may also influence apparent splicing changes. Important findings should be validated using independent datasets or experimental methods, and reports should include the reference genome, annotation release, software versions, statistical thresholds, PSI values, ΔPSI, and relevant read-support information.
- Exon skipping and alternative splice-site selection are therefore essential mechanisms through which eukaryotic cells generate transcript diversity and regulate gene expression. Exon skipping changes whether an entire exon is retained, while alternative donor and acceptor selection changes the boundaries of exons. These events can influence coding sequences, protein structure, RNA stability, and biological function. Combining RNA-seq, splice-junction analysis, transcript isoform quantification, functional annotation, and experimental validation provides a comprehensive approach to understanding these mechanisms in molecular biology, disease research, functional genomics, agriculture, and animal breeding.